Findings

What do systematic reviews say?

996 questions · 1,049 findings · 79 reviews · Dementia and Cognitive Improvement

Sort:Best matchNewestHighest certainty Download CSV

No studies found 240 · 22.9%GRADE not reported 31 · 3%Very low 216 · 20.6%Low 253 · 24.1%Moderate 238 · 22.7%High 71 · 6.8%

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Physical functioning: self‐care ability measured using MOSES Self‐Care Functioning subscale (8–32, higher score indicates poorer function) · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Animal‐assisted therapy (AAT (live animal)) vs robotic animals

Depressive symptoms · people with dementia

The review found no eligible studies for this question.

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Reminiscence therapy vs no treatment

Quality of Life: self‐report · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 1060 participants
Moderate

Reminiscence therapy vs no treatment

Individual: communication at end of treatment · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 96 participants
Very low

Reminiscence therapy vs no treatment

Group: quality of life (self‐reported) at end of treatment · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 1037 participants
High

Reminiscence therapy vs no treatment

Cognition at end of treatment · people with dementia

3 findings from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 1023 participants
High
Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 989 participants
High
Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
14 studies · 1219 participants
High

Reminiscence therapy vs no treatment

Group: communication at end of treatment · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 153 participants
Moderate

Reminiscence therapy vs no treatment

Care home: quality of life (self‐reported) at end of treatment · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 193 participants
Moderate

Reminiscence therapy vs no treatment

Cognitive function · people with dementia

2 findings from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 230 participants
Moderate
Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 196 participants
Moderate

Reminiscence therapy vs no treatment

Care home: communication at end of treatment · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 184 participants
Very low

Reminiscence therapy vs no treatment

Community: quality of life (self‐reported) at end of treatment · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 867 participants
High

Reminiscence therapy vs no treatment

Community: communication and interaction at end of treatment · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 65 participants
Moderate

Reminiscence therapy vs no treatment

Communication and social interaction · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 249 participants
Low

Reminiscence therapy vs no treatment

Functional behaviour at end of treatment · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 1030 participants
Very low

Reminiscence therapy vs no treatment

Agitation and irritability · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 359 participants
Moderate

Reminiscence therapy vs no treatment

Depressed mood · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 973 participants
High

Reminiscence therapy vs no treatment

Stress related to caring (caregiver) · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 1155 participants
Moderate

Reminiscence therapy vs no treatment

Individual: quality of life (self‐reported) at end of treatment · people with dementia

1 finding from 1 review

Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 23 participants
Low

Donepezil 10 mg/day vs placebo

Cognitive function · people with Alzheimer's disease

2 findings from 1 review

Donepezil for dementia due to Alzheimer's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 1130 participants
Moderate
Donepezil for dementia due to Alzheimer's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 1757 participants
Moderate

Donepezil 23 mg/day vs donepezil 10 mg/day

Change in MMSE · people with Alzheimer's disease

1 finding from 1 review

Donepezil for dementia due to Alzheimer's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1370 participants
Moderate